On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
- Research interviews
-
1. Integrating novel digital health technologies into clinical trials
- Mr. Rinol Alaj
-
2. Using real-world insights on drug interactions to inform drug development
- Dr. Amita Datta-Mannan
-
3. The role of preregistration and registered reports in improving research transparency and reproducibility
- Dr. Peter Bonde Ernst-Rasmussen
-
4. Decoding aging: how a proteomic clock predicts mortality and disease across populations
- Dr. M. Austin Argentieri
-
5. Role of ETS2 in autoimmune and inflammatory diseases
- Dr. James Lee
-
6. Restoring glucose metabolism: a new approach to reversing cognitive decline in AD
- Prof. Katrin Andreasson
-
7. The safety, toxicology, and regulation of antibody-drug conjugates
- Dr. Veysel Kayser
-
8. MicroRNA as a biomarker for early detection of amyotrophic lateral sclerosis
- Dr. Sandra Banack
- Dr. Paul Alan Cox
- Dr. Rachael Dunlop
-
10. Cancer vaccines
- Dr. Elias Sayour
-
11. The regulation of cell therapy
- Prof. Moutih Rafei
-
12. How and why neurons die in Alzheimer's disease?
- Prof. Bart De Strooper
-
13. The future of blood tests in cancer treatment
- Dr. Isaac Garcia-Murillas
-
14. Role of marketing authorization holder in drug safety
- Dr. Raphael Elmadjian Pareschi
-
15. Synthetic whole embryo models and their applications
- Prof. Jacob (Yaqub) Hanna
-
16. Scale-up challenges in the production of nanomedicines from lab to industry
- Prof. Dr. Oya Tagit
-
17. Artificial intelligence in precision medicine
- Dr. Michael P. Menden
-
18. Translational medicine: the risk of failure in delay and how to reduce it
- Prof. Martin Wehling
-
19. Challenges and solutions of scaling up
- Dr. Shaukat Ali
-
21. Management of generic drug development: challenges and opportunities
- Mr. Sandeep Patil
-
22. MassBank development and future
- Dr. Emma L. Schymanski
-
23. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
-
24. Translational research in amyotrophic lateral sclerosis (ALS)
- Prof. Aaron D. Gitler
-
25. Rheumatic diseases and musculoskeletal pain
- Prof. Anisur Rahman
-
26. Towards developing a universal influenza vaccine
- Prof. Peter Palese
- Clinical interviews
-
27. PANDAS: a potential link between group A streptococcal infections and neurological disorders
- Prof. P. Patrick Cleary
-
29. Artificial intelligence in guiding cancer treatment decisions
- Prof. Eytan Ruppin
-
30. Characterizing barriers to care in migraine
- Prof. Dawn C. Buse
-
31. Monkeypox: etiopathogenesis, prevention, and treatments
- Dr. Dennis Hruby
-
33. Kidney xenotransplantation
- Dr. Douglas J. Anderson
-
34. CAR-T and TCR-T cellular immunotherapies in oncology
- Prof. Sebastian Kobold
-
35. MAPS: the business of medical affairs
- Dr. Danie du Plessis
-
36. Hypertrophic cardiomyopathy: therapies and treatments
- Prof. Srihari Naidu
-
37. Combating the HIV epidemic
- Prof. William Blattner
-
38. Epigenetic pharmaceuticals used in the clinic
- Dr. Thomas Paul
-
39. Precision cancer medicine: development and future
- Prof. Maurie Markman
-
40. Pediatric cancer testing
- Prof. Joshua Schiffman
-
41. Opposition to vaccination: a transatlantic discussion
- Prof. Jonathan Temte
-
42. Elective caesarean sections from an evolutionary perspective
- Prof. Wenda Trevathan
-
43. Antiphospholipid syndrome and Lupus
- Prof. Graham Hughes
-
44. Prescribing medications to children - a GP’s view
- Dr. Amanda Simmons
Topics Covered
- The process of preregistration and registered reporting in scientific publications
- Impact on research transparency and credibility
- Promoting interdisciplinary work
- Common misconceptions
Biography
Dr. Peter Rasmussen is an Associate Director, Programming at Genmab, where he leads innovative clinical trial analytics and data programming initiatives. He earned his Ph.D. in Integrative Neurophysiology from Københavns Universitet – University of Copenhagen, where his research focused on blood flow, oxygen transport, and energy metabolism in the human brain. Prior to this, he completed his Master of Science in Exercise Physiology at the same institution.
With over two decades of experience in the field, Dr. Peter Rasmussen has contributed extensively to clinical research—publishing more than 90 peer-reviewed articles and assuming pivotal roles in SAS programming, CDISC oversight, and statistical consulting across diverse organizations including Y-mAbs Therapeutics, Lundbeck, and Eurac Research. His interdisciplinary approach and commitment to data-driven decision-making have solidified his reputation as a specialist, scientist, and programmer dedicated to advancing medical research and clinical innovation.
Links
Series:
Categories:
External Links
Talk Citation
Ernst-Rasmussen, P.B. (2025, March 31). The role of preregistration and registered reports in improving research transparency and reproducibility [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 19, 2025, from https://doi.org/10.69645/BXQA6966.Export Citation (RIS)
Publication History
- Published on March 31, 2025
Financial Disclosures
- Dr. Peter Bonde Ernst-Rasmussen has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.